Peppermint and Decongestant Technique on Chronic Sinusitis

ConditionSinus Disease

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age65-80

SponsorAssiut University

About this trial

Chronic rhinosinusitis (CRS) is defined as persistent symptomatic inflammation of the nasal and sinus mucosa that lasts more than 3 months. Epidemiologic studies estimate that 10% to 15% of the US population has CRS with a prevalence of up to 12% in Western populations. CRS is defined as the symptomatic inflammation of the nose and para nasals in uses with the distinction based on the duration of the complaints. CRS is typically described more broadly as an inflammatory disorder and the importance of specific microbial agents in driving the process remains controversial. It is not clear what medical therapy should be followed as the proper treatment for CRS. The most common treatment of CRS includes medical therapy and in cases resistant to medication, endoscopic sinus surgery might be an option. (Kamaneh et al., 2020).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

1- Elderly patients able to communicate. 2- Elderly patients have chronic rhinosinusitis

Disqualifiers

Hypersensitivity 2-Bronchial asthma and spasmophilia 3- Gastroesophageal reflux disease (heartburn)

Trial design

Design model

Parallel

Treatments tested in this trial

Sinus self-massage and inhalation of steated boiled peppermint
Behavioral
The patient should inhale steam from boiled mint leaves twice daily and perform Sinus Self-Massage to relieve nasal and sinus congestion, in addition to taking the prescribed medications.

Treatment groups

108 Participants

are divided into 2 treatment groups

Group A: studyExperimental treatment 1 intervention

Group B: controlNo intervention 0 interventions

Trial outcomes

Primary outcomes

rhinosinusitis-specific scale

the 22-item Sino Nasal Outcome Test (SNOT-22) will be used for measuring quality of life. Each item is categorized into 6 levels (0 for no problem to 5 for the problem is as bad as it can be). The total score is gained by adding the score of each item (range 0-110) with lower scores implying a better health-related quality of life. It covers a wide range of health-related quality of life that may affect patient outcomes. SNOT subscales include 5 questions on rhinological symptoms, 4 questions on ear/facial symptoms, 3 questions on sleep function and 6 questions on psychological function. As with the total SNOT scale, higher scores indicate worse symptoms and lower quality of life

Time frame

3 months

Visual Analog Pain Scale

It was adopted from Chiarotto et al. (2019) and used by the researcher to assess the severity of low back pain. Scoring system: The total scores of the visual analog pain scale ranged from (0-10);

Time frame

3 months

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: